During the past decade, Mehiläinen Kuopio conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mehiläinen Kuopio" are "Hot Flashes" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials), "Dyslipidemic" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Mehiläinen Kuopio" in a lesser frequency.

Most popular intervention types in "Mehiläinen Kuopio" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Elinzanetant (BAY3427080)" (2 trials), "Placebo" (2 trials), "Non-interventional" (1 trials), "Standard of care" (1 trials) and "Vilaprisan (BAY1002670)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mehiläinen Kuopio" are 3 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Mehiläinen Kuopio". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mehiläinen Kuopio, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mehiläinen Kuopio, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".